Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Influenza

Free Subscription 19.01.2026 1 Antiviral Res 1 BMJ 1 Drug Saf 4 Epidemiol Infect 1 J Clin Microbiol 1 J Gen Virol 1 J Infect Dis 1 J Virol 2 J Virol Methods 1 JAMA 1 N Engl J Med 1 Pediatrics 2 PLoS Comput Biol 8 PLoS One 28 Vaccine 2 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. LEEKHA A, Reichel K, Hurst B, Varadarajan N, et al
   Therapeutic intranasal delivery of NanoSTING provides broad protection against seasonal and highly pathogenic influenza strains.
   Antiviral Res. 2026 Jan 14:106342. doi: 10.1016/j.antiviral.2026.106342.
   PubMed         Abstract available
   
   

   
   BMJ

2. MARTIN DS, Doidge JC, Gould D, Shahid T, et al
   The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study.
   BMJ. 2026;392:e085535.
   PubMed         Abstract available
   
   

   
   Drug Saf

3. PALMER M, Seekins D, Avigan M, Marcinak J, et al
   The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.
   Drug Saf. 2026;49:9-25.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

4. WOLMUTH-GORDON HS, Elgohari S, Dabrera G, Green RE, et al
   Estimating influenza A subtype ratios among critical care admissions in England.
   Epidemiol Infect. 2026 Jan 12:1-8. doi: 10.1017/S0950268825100812.
   PubMed        
   
   
5. KOKAVECZ L, Sohajda Z, David P, Stagel A, et al
   Incidence of parvovirus B19 among Hungarian blood donor population during COVID-19 restrictions and the subsequent B19 epidemic of 2024.
   Epidemiol Infect. 2026;154:e11.
   PubMed         Abstract available
   
   
6. BEJKO D, Vergison A, Stranges S, Mossong J, et al
   Protection from second booster vaccines and natural immunity against SARS-CoV-2 infections, 2022-2023.
   Epidemiol Infect. 2025;154:e10.
   PubMed         Abstract available
   
   
7. CAREY C, O'Moore E, Huyton R, Willner S, et al
   COVID-19 outbreaks in care homes: How does size influence transmission dynamics? A cross-sectional study with implications for outbreak management in small care homes.
   Epidemiol Infect. 2025;154:e8.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

8. BIGAUD B, Marjanovic N, Deroche L, Drugeon B, et al
   Impact of multiplex PCR point-of-care platform implementation for respiratory pathogen detection in an emergency department with high daily patient volume.
   J Clin Microbiol. 2026;64:e0131325.
   PubMed         Abstract available
   
   

   
   J Gen Virol

9. GERODEZ A, Dufrasne FE, Denis O, Steensels M, et al
   The cellular activating protein-1 cFos regulates influenza A virus replication.
   J Gen Virol. 2026;107:002194.
   PubMed         Abstract available
   
   

   
   J Infect Dis

10. SKOWRONSKI DM, Ranadheera C, Kaweski SE, Sabaiduc S, et al
    Cross-reactive H5N1 neuraminidase antibodies by age and influenza A imprinting cohorts of the past century: population-based serosurvey, British Columbia, Canada.
    J Infect Dis. 2026 Jan 16:jiag030. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

11. CONG G, Li H, Li L, Chen J, et al
    The newly developed porcine-origin parainfluenza virus PIV5-JS17 serves as an exogenous gene delivery system for swine.
    J Virol. 2026 Jan 13:e0185825. doi: 10.1128/jvi.01858.
    PubMed         Abstract available
    
    

    
    J Virol Methods

12. ZHANG W, Chen XY, Lin SX
    Search and prove of efficient inhibitors against papain-like protease from SARS-CoV-2.
    J Virol Methods. 2026;341:115329.
    PubMed         Abstract available
    
    
13. EPTAMINITAKI GC, Zafiropoulos A, Sourvinos G
    Evaluation of summation operator-MM molecular medium for the SARS-CoV-2 RNA stability over 90 days under different temperature conditions.
    J Virol Methods. 2026;341:115322.
    PubMed         Abstract available
    
    

    
    JAMA

14. MCCLYMONT E, Blitz S, Forward L, Cole S, et al
    The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy.
    JAMA. 2025 Dec 15:e2521001. doi: 10.1001/jama.2025.21001.
    PubMed         Abstract available
    
    

    
    N Engl J Med

15. LAMPERT R, Harmon KG
    Sudden Cardiac Arrest in Athletes.
    N Engl J Med. 2026;394:268-280.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. HAMDAN O, Amarin JZ, Antoon JW, Stopczynski T, et al
    Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic.
    Pediatrics. 2026 Jan 14:e2025071898. doi: 10.1542/peds.2025-071898.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

17. WANG Z, Zhou Z, Wang J, Yang L, et al
    Characterization of the heterogeneity in SARS-CoV-2 fitness dynamics via graph representation learning.
    PLoS Comput Biol. 2026;22:e1013582.
    PubMed         Abstract available
    
    
18. MAYER-BLACKWELL K, Minervina A, Pogorelyy M, Rawat P, et al
    TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypes.
    PLoS Comput Biol. 2026;22:e1013767.
    PubMed         Abstract available
    
    

    
    PLoS One

19. ORSOLIC BESLIC A, Caljkusic K, Matana A, Tomelic Ercegovic K, et al
    Evaluation of cerebrovascular reactivity using transcranial Doppler in patients with influenza.
    PLoS One. 2026;21:e0340768.
    PubMed         Abstract available
    
    
20. SCHNEIDER JL, Rivelli JS, Escaron AL, Crocker R, et al
    Impact of COVID-19 on colorectal cancer screening in a federally qualified health center: Provider and staff perspectives.
    PLoS One. 2026;21:e0340184.
    PubMed         Abstract available
    
    
21. VINER RM, Pearce A, Hope S
    The impact of school absence on mental health in children and young people: Analysis of an English national birth cohort.
    PLoS One. 2026;21:e0336137.
    PubMed         Abstract available
    
    
22. MANN H, Dimon E, Zhang Y, Arroyo N, et al
    Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017-2023).
    PLoS One. 2026;21:e0340347.
    PubMed         Abstract available
    
    
23. ZENG Z, Sathasivam S, Xin J, Zhao H, et al
    Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases.
    PLoS One. 2026;21:e0339304.
    PubMed         Abstract available
    
    
24. RIBEIRO HS, Mondini DR, Santa-Catharina GP, Marcal L, et al
    Skeletal muscle-kidney crosstalk in a cohort of critical illness survivors.
    PLoS One. 2026;21:e0339795.
    PubMed         Abstract available
    
    
25. BAI Y, Cao P, Kim C, Ienciu K, et al
    Longitudinal trends in vaping, smoking, and harmful alcohol use across sexual orientations in the UK (2014-2021).
    PLoS One. 2026;21:e0339847.
    PubMed         Abstract available
    
    
26. AKTER N, Zerin FF, Banu B, Kanta FA, et al
    Quality of life in hypertensive patients using the WHOQOL-BREF instrument in the post-pandemic Bangladesh: A cross-sectional study.
    PLoS One. 2026;21:e0340897.
    PubMed         Abstract available
    
    

    
    Vaccine

27. DE WALS P, Papenburg J, Gilca R, Brousseau N, et al
    Are hemagglutinin-only influenza vaccines as effective as conventional influenza vaccines against severe infection?
    Vaccine. 2026;74:128234.
    PubMed        
    
    
28. CHENG K, Pullenayegum E, Singh P, Loeb M, et al
    Use of composite outcomes in cluster randomized control trials of influenza vaccines.
    Vaccine. 2026;74:128224.
    PubMed         Abstract available
    
    
29. PAGE CL, Holbrook BC, Miller LD, Grayson JM, et al
    TLR5 versus TLR7/8 agonist-dependent modulation of the early gene expression response to inactivated influenza virus vaccine in newborn nonhuman primates.
    Vaccine. 2026;74:128163.
    PubMed         Abstract available
    
    
30. HARKER EJ, Lewis NM, Johnson CA, Zhu Y, et al
    Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024.
    Vaccine. 2026;74:128192.
    PubMed         Abstract available
    
    
31. DE BRABANDERE L, Herzog SA, Desombere I, Arien KK, et al
    Enhanced immune responses to mRNA compared with adenoviral vector COVID-19 vaccines during pregnancy: implications for pandemic preparedness.
    Vaccine. 2026;73:128153.
    PubMed         Abstract available
    
    
32. ORELLANA-MANZANO A, Garcia-Angulo A, Quinto F, Munizaga MG, et al
    COVID-19 vaccination campaign, knowledge, and trust in Duran, Ecuador: a cross-sectional study.
    Vaccine. 2026;72:127867.
    PubMed         Abstract available
    
    
33. YE G, Qu C, Liao Z, Wu R, et al
    Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine.
    Vaccine. 2026;73:128190.
    PubMed         Abstract available
    
    
34. ZHU Z, Chen Z, Gao Y, Xie Z, et al
    Genetic distance predicts neutralizing antibody titers for monovalent and bivalent SARS-CoV-2 vaccines.
    Vaccine. 2026;73:128185.
    PubMed         Abstract available
    
    
35. BREZNIK JA, Ang JC, Bhakta H, Liu LM, et al
    Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents.
    Vaccine. 2025;73:128160.
    PubMed         Abstract available
    
    
36. OKABE H, Hashimoto K, Asano Y, Sato M, et al
    Adverse events post-BNT162b2 vaccination in Japanese children.
    Vaccine. 2025;73:128167.
    PubMed         Abstract available
    
    
37. DANIEL N, Smith C, Miah N, Akroyd C, et al
    Enablers and barriers to participation in vaccine trials: a narrative synthesis.
    Vaccine. 2025;73:128183.
    PubMed         Abstract available
    
    
38. REITER PL, Katz ML
    Vaccine hesitancy among midlife and older adults in the United States.
    Vaccine. 2025;72:128054.
    PubMed         Abstract available
    
    
39. BALLOUT S, Darwish SA, Kelly PJ, Keller T, et al
    The use of storytelling in COVID-19 vaccine promotion: A scoping review of interventions and campaigns.
    Vaccine. 2025;72:128098.
    PubMed         Abstract available
    
    
40. PARIDANS M, Gillain N, Husson E, Darcis G, et al
    COVID-19 vaccination: Does knowledge of higher immunity influence first and second COVID-19 booster uptake? A study carried out in a university population.
    Vaccine. 2025;72:128057.
    PubMed         Abstract available
    
    
41. PAL SS, Kim KH, Bhatnagar N, Grovenstein P, et al
    A combination of new prefusion mRNA and protein vaccines enhances neutralizing antibodies and protection against respiratory syncytial virus.
    Vaccine. 2025;73:128154.
    PubMed         Abstract available
    
    
42. ALVES K, Kouassi A, Nelson J, Plested JS, et al
    Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial.
    Vaccine. 2025;73:128164.
    PubMed         Abstract available
    
    
43. MIRON E, Sauvageau C, Dube E, Vivion M, et al
    Vaccine hesitancy among older adults, urban indigenous and newcomers in Canada: A qualitative comparative study.
    Vaccine. 2025;73:128143.
    PubMed         Abstract available
    
    
44. STRENG BMM, Hensen LCM, Delemarre EM, Binnendijk RS, et al
    Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.
    Vaccine. 2025;73:128079.
    PubMed         Abstract available
    
    
45. LARSEN FD, Juhl AK, Dietz LL, Nielsen H, et al
    Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy.
    Vaccine. 2025;73:128155.
    PubMed         Abstract available
    
    
46. SEESKIN ZH, Steffan M, Geistwhite B, Yarbrough M, et al
    Using latent class analysis of survey data to explore parent behaviors and attitudes regarding children's COVID vaccinations.
    Vaccine. 2025;73:128149.
    PubMed         Abstract available
    
    
47. TIPTON T, Laidlaw S, Nguyen D, Longet S, et al
    ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation.
    Vaccine. 2026;72:128123.
    PubMed         Abstract available
    
    
48. KOVACS D, Brar G, Anthony SJ, Wang LF, et al
    Initiation of a coronavirus vaccine library.
    Vaccine. 2025;72:128140.
    PubMed         Abstract available
    
    
49. HARO SLY MJ, Zubeldia L
    COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil.
    Vaccine. 2025;72:128141.
    PubMed         Abstract available
    
    
50. JABBAR F, Kadhim KA, Alhilfi RA, Al Khafaji IS, et al
    Advancements in monitoring adverse events following immunization in Iraq: Insights from the CIVIE project 2022-2023.
    Vaccine. 2026;72:128121.
    PubMed         Abstract available
    
    
51. SINCLAIR JE, Mayfield HJ, Lu H, Brown SJ, et al
    Estimating risk of long COVID using a Bayesian network-based decision support tool.
    Vaccine. 2026;72:128127.
    PubMed         Abstract available
    
    
52. DRISLANE S, Moore H, Attwell K
    Understanding parental decisions to decline or delay infant RSV immunisation, nirsevimab, in Western Australia in 2024.
    Vaccine. 2026;72:128133.
    PubMed         Abstract available
    
    
53. MADIA JE, Nicodemo C, Petrou S, de Lusignan S, et al
    Primary healthcare costs associated with the AstraZeneca COVID-19 vaccine in England.
    Vaccine. 2025;72:128067.
    PubMed         Abstract available
    
    
54. HAYASHI K, Hashimoto N, Hashimoto C, Takeuchi Y, et al
    Effect of completed COVID-19 vaccination on serum interferon lambda3: a single-center retrospective study.
    Vaccine. 2025;72:128108.
    PubMed         Abstract available
    
    

    
    Virology

55. THOMAS MH, Carlock MA, Ross TM
    Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone.
    Virology. 2026;616:110787.
    PubMed         Abstract available
    
    
56. IINO Y, Sato K, Furuse Y, Isogai E, et al
    Human parainfluenza virus type 3 viruses with the furin-susceptible motif at the cleavage site of the fusion protein arose from original wild strains during their propagation in vitro.
    Virology. 2026;617:110797.
    PubMed         Abstract available
    
    

    
    Virus Res

57. CAI H, Hou L, Chang J, Yang Q, et al
    Venenum bufonis and its active constituents alleviate RSV-induced pneumonia in mice by suppressing macrophage infiltration and NLRP3 inflammasome activation.
    Virus Res. 2026;363:199672.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.